Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

(2020) Aonghus Lavelle et al.   Nature Reviews Gastroenterology & Hepatology

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review

(2020) Dominika Jakubczyk et al.   Nutrients

Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting β-galactosidase

(2020) Qing Li et al.   GASTROENTEROLOGY

Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring?

(2020) Marjorie Argollo et al.   Nature Reviews Gastroenterology & Hepatology

Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism

(2020) Xiaojiao Zheng et al.   Cell Metabolism

Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice

(2019) Graham J. Britton et al.   IMMUNITY

The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases

(2019) Mathias L. Richard et al.   Nature Reviews Gastroenterology & Hepatology

Gut microbiota in neurodegenerative disorders

(2019) Suparna Roy Sarkar et al.   JOURNAL OF NEUROIMMUNOLOGY

Apolipoprotein A-I mimetics mitigate intestinal inflammation in a COX2-dependent inflammatory disease model

(2019) David Meriwether et al.   JOURNAL OF CLINICAL INVESTIGATION

Review article: fungal alterations in inflammatory bowel diseases

(2019) Siu Lam et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Highly potent non-steroidal FXR agonists protostane-type triterpenoids: Structure-activity relationship and mechanism

(2019) Zhi-Lin Luan et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A single faecal microbiota transplantation modulates the microbiome and improves clinical manifestations in a rat model of colitis

(2019) Marina Lleal et al.   EBioMedicine

Alisma orientale extract exerts the reversing cholestasis effect by activation of farnesoid X receptor

(2018) Xiao-Kui Huo et al.   PHYTOMEDICINE

Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition

(2018) Alba Rodríguez-Nogales et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer

(2018) Vishal Singh et al.   CELL

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

(2018) Lulu Sun et al.   NATURE MEDICINE

Gut microbiome structure and metabolic activity in inflammatory bowel disease

(2018) Eric A. Franzosa et al.   Nature Microbiology

Intestinal Epithelial Sirtuin 1 Regulates Intestinal Inflammation During Aging in Mice by Altering the Intestinal Microbiota

(2017) Alicia S. Wellman et al.   GASTROENTEROLOGY

A microbial signature for Crohn's disease

(2017) Victoria Pascal et al.   GUT

Two new compounds from a marine-derived Streptomyces sp.

(2017) Si-Yu Zhou et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

Chemically induced mouse models of acute and chronic intestinal inflammation

(2017) Stefan Wirtz et al.   Nature Protocols

Gut microbiota and IBD: causation or correlation?

(2017) Josephine Ni et al.   Nature Reviews Gastroenterology & Hepatology

Fungal microbiota dysbiosis in IBD

(2016) Harry Sokol et al.   GUT

The microbiome and innate immunity

(2016) Christoph A. Thaiss et al.   NATURE

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands

(2016) Bruno Lamas et al.   NATURE MEDICINE

Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease

(2016) G. Hoarau et al.   mBio

Gut Fungal Microbiota

(2015) Mathias L. Richard et al.   INFLAMMATORY BOWEL DISEASES

Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease

(2015) Christel Chehoud et al.   INFLAMMATORY BOWEL DISEASES

Endocannabinoids — at the crossroads between the gut microbiota and host metabolism

(2015) Patrice D. Cani et al.   Nature Reviews Endocrinology

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

(2014) Aleksandar D. Kostic et al.   GASTROENTEROLOGY

Role of farnesoid X receptor in inflammation and resolution

(2014) Firdose Begum Shaik et al.   INFLAMMATION RESEARCH

The ion channel TRPV1 regulates the activation and proinflammatory properties of CD4+ T cells

(2014) Samuel Bertin et al.   NATURE IMMUNOLOGY

Nuclear receptors in the cross-talk of drug metabolism and inflammation

(2013) Sabine Gerbal-Chaloin et al.   DRUG METABOLISM REVIEWS

Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver

(2013) Jeff L. Staudinger et al.   DRUG METABOLISM REVIEWS

Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis

(2012) I. D. Iliev et al.   SCIENCE

Bacteria in the pathogenesis of inflammatory bowel disease

(2011) Paul Flanagan et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Metabolic engineering of microbial pathways for advanced biofuels production

(2011) Fuzhong Zhang et al.   CURRENT OPINION IN BIOTECHNOLOGY

Pathway engineering for functional isoprenoids

(2011) Norihiko Misawa   CURRENT OPINION IN BIOTECHNOLOGY

Microbial production of farnesol (FOH): Current states and beyond

(2011) Chonglong Wang et al.   PROCESS BIOCHEMISTRY

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fungi and inflammatory bowel diseases: Alterations of composition and diversity

(2008) Stephan J. Ott et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY